NORLEVO

This brand name is authorized in Cyprus, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Netherlands, Tunisia, South Africa

Active ingredients

The drug NORLEVO contains one active pharmaceutical ingredient (API):

1 Levonorgestrel
UNII 5W7SIA7YZW - LEVONORGESTREL

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.

Read about Levonorgestrel

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NORLEVO Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03AC03 Levonorgestrel G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC03
G03AD01 Levonorgestrel G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AD Emergency contraceptives
Discover more medicines within G03AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 3400936413726, 67770, BE277356
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 025691
Country: FR Base de données publique des médicaments Identifier(s): 60812935
Country: HK Department of Health Drug Office Identifier(s): 55593
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 5265
Country: JP 医薬品医療機器総合機構 Identifier(s): 254900AF2024
Country: NL Z-Index G-Standaard, PRK Identifier(s): 78921
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 4983011, 4983012
Country: ZA Health Products Regulatory Authority Identifier(s): 33/21.8.2/0471

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.